MOTS-c and Glaucoma: A Mitochondrial Signal With Bigger Implications Than Eye Pressure?
In 2015, researchers discovered MOTS-c โ a 16-amino-acid peptide encoded in mitochondrial DNA (mtDNA) (). It is produced from a short open reading...
Deep research and expert guides on maintaining your visual health.
In 2015, researchers discovered MOTS-c โ a 16-amino-acid peptide encoded in mitochondrial DNA (mtDNA) (). It is produced from a short open reading...
Visual field loss from conditions like glaucoma can go unnoticed. Start a free trial and screen for potential blind spots in minutes.
MOTS-c is a tiny peptide produced inside mitochondria, the structures in cells that generate energy. It acts like a signaling molecule, communicating metabolic state and helping cells adapt to stress by influencing how they use glucose and fats. MOTS-c can move within the cell and into the bloodstream to affect other tissues, and it supports mitochondrial function and resilience. Research shows it can improve insulin sensitivity, enhance aspects of physical performance, and reduce some forms of inflammation, making it relevant to metabolic health. One key action of MOTS-c is activating energy-sensing pathways that shift cells toward maintenance and efficient fuel use, which is helpful when energy is scarce. Because mitochondrial function often declines with age and disease, MOTS-c is of interest as a potential way to restore cellular energy balance and protect tissues. Scientists are exploring whether increasing MOTS-c activity or delivering it therapeutically could help with conditions like metabolic disorders, muscle weakness, and age-related decline. While early findings are promising, more work is needed to determine safe doses, delivery methods, and long-term effects.